Enrofloxacin

DB11404InvestigationalVet approvedSmall molecule

Enrofloxacin is an antibiotic agent from the fluoroquinolone family produced by the Bayer Corporation. Enrofloxacin is approved by the FDA for its veterinary use. Due to the identification of fluoroquinolone-resistant... Due to the identification of fluoroquinolone-resistant strains of Campylobacter, in September 2005, the FDA withdrew the approval of enrofloxacin for its use in water to treat flocks of poultry.

Chemical structure of Enrofloxacin
Mechanism
Curator reviewed
Formula / weight
C19H22FN3O3 · 359.3947 g/mol (avg)
Code names
BAY VP 2674

Resolves to

Compound
UNII3DX3XEK1BNCAS93106-60-6ChEMBLCHEMBL15511ChEBI35720KEGGD02473
Clinical / RWD
RxNorm24192
Structure
InChIKeySPFYMRJSYKOXGV-UHFFFAOYSA-NSMILESCCN1CCN(CC1)C1=CC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O
Targets
P0AES4gyrA
Transporters
P08183ABCB1Q9UNQ0ABCG2

What you can answer from here — as of August 28, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
623Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
24+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Enrofloxacin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In